首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical medicine insights-oncology

缩写:

ISSN:N/A

e-ISSN:1179-5549

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引526
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Donya Salmasinia,Myron Chang,John R Wingard et al. Donya Salmasinia et al.
Interferon alpha (IFN-α) has been used as a maintenance therapy after autologous stem cell transplantation (ASCT) for multiple myeloma (MM) patients. In this study, we combined GM-CSF with IFN-α in order to improve IFN tolerance in post-A...
Geetanjali Gupta,Reecha Singh,Kathirvelu Shanmugasamy et al. Geetanjali Gupta et al.
We present a case of basal cell adenocarcinoma (BCAC) in the tongue in a 65-year old male. This is an extremely rare presentation. BCAC generally occurs in the parotid gland and rarely involves the minor salivary glands. Few cases have been...
Bhanu Vakkalanka,Mohammed Milhem Bhanu Vakkalanka
Introduction: Splenic angiosarcoma is a rare tumor with only a few cases reported in the literature. Surgical resection offers the best chance of cure for this aggressive neoplasm but is often precluded by infiltration of...
Joshua M Lang,Michael R Harrison Joshua M Lang
Dramatic advances in the care of patients with advanced renal cell carcinoma have occurred over the last ten years, including insights into the molecular pathogenesis of this disease, that have now been translated into paradigm-changing the...
Atara Ntekim,Adeniyi Adenipekun,Bidemi Akinlade et al. Atara Ntekim et al.
Iridium-192 is widely used for high-dose rate brachytherapy. Co-60 source with similar geometric and dosimetric properties are now available. It has a longer half life but higher energy than Iridium-192. If Co-60 source can produce similar ...
Sumanta Kumar Pal,Robert A Figlin Sumanta Kumar Pal
THE AGENTS CURRENTLY APPROVED FOR USE IN METASTATIC RENAL CELL CARCINOMA (MRCC) CAN BE DIVIDED BROADLY INTO TWO CATEGORIES: (1) vascular endothelial growth factor receptor (VEGFR)-directed therapies or (2) inhibitors of the mammalian target...
Esther Uña Cidón Esther Uña Cidón
Colorectal cancer (CRC) is a very common disease with a high rate of mortality around the world, representing the second most frequent cause of cancer-related death. As the majority of patients are diagnosed with advanced cancer with a subs...
Joseph F Murphy Joseph F Murphy
Modulation of the immune system for therapeutic ends has a long history, stretching back to Edward Jenner's use of cowpox to induce immunity to smallpox in 1796. Since then, immunotherapy, in the form of prophylactic and therapeutic vaccine...
Atara I Ntekim,Ayo M Folasire Atara I Ntekim
Background: Highly Active Anti Retroviral Treatment (HAART) improves the outcome of HIV positive patients treated for cancer. In our center HAART is only commenced in HIV positive patients with malignancy if the CD4 T lym...
Rodrigo Lopes da Silva,Patrícia Ribeiro,Natacha Abreu et al. Rodrigo Lopes da Silva et al.
Background: Invasive aspergillosis (IA) is a major cause of morbidity and mortality in profoundly neutropenic patients, so early diagnosis is mandatory. A...